Serán Speaking at the Global Drug Bioavailability Enhancement Summit

Tuesday, June 25th and Wednesday, June 26th, 2024

Hyatt Regency, Princeton, New Jersey

‍

Serán's executives will be exhibiting and Erica Schlesinger, PhD will be delivering a talk at the 2024 Global Drug Bioavailability Enhancement / Controlled & Modified Drug Release Summit at the Hyatt Regency Princeton, Princeton, NJ.

Interested to learn more? Check out the full program agenda here: AGENDA

Interested to attend? Save $200 on attending with code SPEAKER200. Hope you can join us!

‍

Session Title: Strategies for ASD Formulation Development

Speaker: Erica Schlesinger, PhD

‍

In this talk, we will present a multifaceted approach to technology selection for enabled formulations. We demonstrate how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design. For successful development of a rapidly advanceable and patient-friendly enabled drug product, the development of the drug product intermediate cannot be decoupled from the drug product design. We introduce a case study that highlights these principles and strategies in addition to providing a comprehensive overview of ASD formulation and drug product design principles.

‍

KEY TAKEAWAYS:

1. Considerations for spray drying vs. HME in early development

2. Considering TPP/Product Design in ASD screening

3. Considering impact of particle properties (SDD vs HME) in product design & performance

Contact us today to learn more about Serán's science and how we're working through tough treatment problems to bring new delivery solutions to patients, sooner.

‍